New RSV shot for infants approved by CDC

(WASHINGTON) -- A new immunization to protect infants from respiratory syncytial virus, or RSV was approved by the Centers for Disease Control and Prevention on Thursday.The approved drug called nirsevimab, which will be marketed in the U.S. by Sanofi as Beyfortus, was recommended unanimously... Read More.